Literature DB >> 4611434

Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 8: Clinical investigation. Use of a flexible dosage schedule in a double-blind comparison of loperamide with diphenoxylate in 614 patients suffering from acute diarrhea.

J Dom, R Leyman, V Schuermans, J Brugmans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4611434

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  4 in total

1.  Effect of loperamide on fecal output and composition in well-established ileostomy and ileorectal anastomosis.

Authors:  G N Tytgat; K Huibregtse; J Dagevos; A van den Ende
Journal:  Am J Dig Dis       Date:  1977-08

2.  Double-blind placebo-controlled study of loperamide (Imodium) in chronic diarrhoea caused by ileocolic disease or resection.

Authors:  P Mainguet; R Fiasse
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

Review 3.  Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-01       Impact factor: 9.546

4.  Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea.

Authors:  J A Maroun; L B Anthony; N Blais; R Burkes; S D Dowden; G Dranitsaris; B Samson; A Shah; M P Thirlwell; M D Vincent; R Wong
Journal:  Curr Oncol       Date:  2007-02       Impact factor: 3.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.